That XOMA gets some royalty from DNA on Lucentis has been disclosed; I was looking for a quantitative assessment of the royalty
Don't quote me on this but I thought I heard on one of the calls an analyst talking as if 1% was the royalty and not being disputed. This is going from memory. Here is a quote from a PR would seem to be consistent too. Sorry don't know the x-US portion of your question.
"Royalty percentages on BCE licenses range from 0.5% to 3% of net sales, and the royalty on LUCENTIS(tm) is toward the lower end of this range."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.